Results 1 to 10 of about 335,621 (200)

Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants.

JAMA Ophthalmol, 2023
Importance Calcium channel blocker (CCB) use has been associated with an increased risk of glaucoma in exploratory studies. Objective To examine the association of systemic CCB use with glaucoma and related traits among UK Biobank participants ...
Alan Kastner, K. Stuart, Giovanni Montesano, C. D. De Moraes, J. H. Kang, J. Wiggs, Louis R. Pasquale, P. Hysi, S. Chua, P. Patel, P. Foster, P. Khaw, A. Khawaja, N. Allen, Tariq Aslam, D. Atan, K. Balaskas, S. Barman, J. Barrett, P. Bishop, Graeme Black, Tasanee Braithwaite, R. Carare, U. Chakravarthy, M. Chan, S. Chua, A. Day, Parul Desai, B. Dhillon, A. Dick, A. Doney, C. Egan, Sarah Ennis, P. Foster, M. Fruttiger, John Gallacher, D. Garway-Heath, Jane Gibson, J. Guggenheim, C. Hammond, A. Hardcastle, Simon Harding, R. Hogg, P. Hysi, P. Keane, P. Khaw, A. Khawaja, G. Lascaratos, Thomas J Littlejohns, A. Lotery, R. Luben, P. Luthert, Tom J. MacGillivray, S. Mackie, S. Madhusudhan, B. Mcguinness, G. McKay, M. Mckibbin, T. Moore, Jonathan H. Morgan, Eoin O'sullivan, R. Oram, C. Owen, Praveen J. Patel, E. Paterson, T. Peto, Axel Petzold, Nikolas Pontikos, J. Rahi, A. Rudnicka, Naveed Sattar, Jay Self, P. Sergouniotis, S. Sivaprasad, David Steel, Irene Stratton, N. Strouthidis, C. Sudlow, Zihan Sun, Robyn Tapp, D. Thomas, E. Trucco, A. Tufail, Ananth C. Viswanathan, V. Vitart, M. Weedon, Katie M. Williams, Cathy Williams, J. Woodside, M. Yates, Yalin Zheng   +90 more
semanticscholar   +2 more sources

The fourth-generation Calcium channel blocker: Cilnidipine

Indian Heart Journal, 2013
Several classes of antihypertensive agents have been in clinical use, including diuretics, α-blockers, β-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin II type 1 receptor blockers (ARB), and organic calcium channel blockers (CCBs).
K. Sarat Chandra, G. Ramesh
doaj   +2 more sources

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose [PDF]

Journal of Investigative Medicine High Impact Case Reports
Beta-blockers and calcium channel blockers are among the most commonly used drugs in the adult population, and the National Poison Data System annual reports note 11 075 beta-blocker overdoses and 6256 calcium-channel blocker overdoses in 2022. Poisoning
Varun Roperia MD, Ahmed Zia Kiani MD, Naveen Jayakumar MD   +2 more
doaj   +2 more sources

Calcium Channel Blocker Toxicity: A Practical Approach [PDF]

Journal of Multidisciplinary Healthcare, 2022
Omar A Alshaya,1– 3 Arwa Alhamed,3,4 Sara Althewaibi,1 Lolwa Fetyani,1 Shaden Alshehri,1 Fai Alnashmi,1 Shmeylan Alharbi,1– 3 Mohammed Alrashed,1– 3,5 Saleh F Alqifari,6 Abdulrahman I Alshaya1– 3 1Department of Pharmacy Practice, College of Pharmacy ...
Alshaya OA, Alhamed A, Althewaibi S, Fetyani L, Alshehri S, Alnashmi F, Alharbi S, Alrashed M, Alqifari SF, Alshaya AI   +9 more
doaj   +2 more sources

Calcium Channel Blocker Overdose. [PDF]

Journal of education & teaching in emergency medicine
Emergency medicine residents and medical students on emergency medicine rotation.Calcium channel blocker (CCB) overdoses can be severe with potentially serious adverse outcomes. CCBs work by blocking the calcium channels on smooth and cardiac muscle tissue. At low dose ranges, dihydropyridine CCBs (such as nifedipine, amlodipine, and nicardipine) block
Andrusaitis, MD, MS, Jessica G., Givertz, MD, Alan   +1 more
openaire   +4 more sources

Successful treatment of severe calcium channel blocker poisoning, new experience with the guidance of invasive hemodynamic monitoring in a 17-year-old girl: a case report [PDF]

Journal of Medical Case Reports
Background Calcium channel blocker poisoning is one of the most lethal cardiac drugs overdoses. Calcium and high-dose insulin infusion are the first-line therapy for symptomatic patients, and Intralipid emulsion infusion is useful for refractory cases ...
Amir Saeed, Amir Naghshzan
doaj   +2 more sources

Effect of Dihydropyridine Calcium Channel Blocker on Mortality of Hypertension Patients With Moderate-Severe Pulmonary Acute Respiratory Distress Syndrome: A Multicenter Retrospective Observational Cohort Study

Critical Care Explorations, 2021
OBJECTIVES:. The aim was to evaluate the effect of dihydropyridine calcium channel blocker on the prognosis for moderate-severe pulmonary acute respiratory distress syndrome in hypertension patients. DESIGN:.
Fengyuan Li, MD, Chang Gao, MD, Jiahao Chen, MD, Ling Yang, MD, Shiqi Guo, MD, Dongmei Jin, MD, Xiaoting Lu, MD, Yin Sheng, MD, Xiaoxia Ji, MD, Qiang Guo, MD   +9 more
doaj   +1 more source

Intravenous calcium therapy in calcium channel blocker poisoning – A double-edged sword [PDF]

Journal of Anaesthesiology Clinical Pharmacology
Balaji Rajaram, Rajathadri H. Ravikumar, Shashikant Sharma, Puneet Khanna   +3 more
doaj   +2 more sources

Development of severe junctional bradycardia after dexmedetomidine infusion in a polypharmacy patient: a case report and literature review [PDF]

Kosin Medical Journal, 2023
The authors report a case of newly manifested severe junctional bradycardia following dexmedetomidine administration during spinal anesthesia in a polypharmacy patient.
Soeun Jeon, Eunsoo Kim, Sun Hack Lee, Sung In Paek, Hyun-Su Ri, Dowon Lee   +5 more
doaj   +1 more source

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS

Рациональная фармакотерапия в кардиологии, 2015
Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented.
A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta   +3 more
doaj   +3 more sources